Article
BPSA Summit Postponed for Fall 2020 After COVID-19 Outbreak
Author(s):
The decision comes after a state-of-emergency was declared in Washington, DC, due to the ongoing outbreak of COVID-19.
On March 16, 2020, Kevin Ott, director of the Bio-Process Systems Alliance (BPSA) announced in an email to BPSA members and contacts that the BPSA Summit scheduled for July 15–17, 2020 in Washington, DC, will be postponed for a later date in fall 2020. The decision comes after a state-of-emergency was declared in Washington, DC, due to the ongoing outbreak of COVID-19.
“The decision to postpone our 10th Anniversary BPSA Summit was not an easy one to make, but we believe this is the proper course of action given the uncontrollable externalities we all face at the moment,” Ott said in the email. “We believe this to be a prudent business decision, and it is unanimously supported by the BPSA [e]xecutive [c]ommittee.”
Source: BPSA
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
